Utility of oral valganciclovir for the treatment of cytomegalovirus disease after renal transplantation.
Pegues
David A
DA
David Geffen School of Medicine, UCLA Division of Infectious Diseases, 37-121 CHS 10833 Le Conte Avenue, Los Angeles, CA 90095-1688, USA. dpegues@mednet.ucla.edu